<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27422383</article-id>
      <article-id pub-id-type="pmc">4947274</article-id>
      <article-id pub-id-type="publisher-id">633</article-id>
      <article-id pub-id-type="doi">10.1186/s12883-016-0633-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hyperekplexia, microcephaly and simplified gyral pattern caused by novel <italic>ASNS</italic> mutations, case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <name>
            <surname>Seidahmed</surname>
            <given-names>Mohammed Zain</given-names>
          </name>
          <address>
            <email>zainsidahmed@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Salih</surname>
            <given-names>Mustafa A.</given-names>
          </name>
          <address>
            <email>mustafa_salih05@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abdulbasit</surname>
            <given-names>Omer B.</given-names>
          </name>
          <address>
            <email>omerabdelbasit@yahoo.co.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Samadi</surname>
            <given-names>Abdulmohsen</given-names>
          </name>
          <address>
            <email>smadi1979@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Al Hussien</surname>
            <given-names>Khalid</given-names>
          </name>
          <address>
            <email>kalhussein9@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miqdad</surname>
            <given-names>Abeer M.</given-names>
          </name>
          <address>
            <email>amiqdad@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Biary</surname>
            <given-names>Maha S.</given-names>
          </name>
          <address>
            <email>mahasoudan@icloud.com</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alazami</surname>
            <given-names>Anas M.</given-names>
          </name>
          <address>
            <email>AmAlazami@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alorainy</surname>
            <given-names>Ibrahim A.</given-names>
          </name>
          <address>
            <email>alorainy@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kabiraj</surname>
            <given-names>Mohammad M.</given-names>
          </name>
          <address>
            <email>kabirajmmu@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shaheen</surname>
            <given-names>Ranad</given-names>
          </name>
          <address>
            <email>rshaheen@kfshrc.edu.sa</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alkuraya</surname>
            <given-names>Fowzan S.</given-names>
          </name>
          <address>
            <email>alkuraya@outlook.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4"/>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <aff id="Aff1"><label/>Neonatology Unit, Department of Pediatrics, Security Forces Hospital, Riyadh, 11481 Saudi Arabia </aff>
        <aff id="Aff2"><label/>Division of Pediatric Neurology, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia </aff>
        <aff id="Aff3"><label/>Pediatric Neurology, Department of Pediatrics, Security Forces Hospital, Riyadh, Saudi Arabia </aff>
        <aff id="Aff4"><label/>Developmental Genetics Unit, Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia </aff>
        <aff id="Aff5"><label/>Department of Radiology and Diagnostic Imaging, King Khalid University Hospital and College of Medicine, King Saud University, Riyadh, Saudi Arabia </aff>
        <aff id="Aff6"><label/>Division of Clinical Neurophyisoloy, Department of Neuroscience, Prince Sultan Medical City, Riyadh, Saudi Arabia </aff>
        <aff id="Aff7"><label/>Department of Anatomy and Cell Biology, College of Medicine, Al Faisal University, Riyadh, Saudi Arabia </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>15</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>105</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Asparagine synthetase deficiency (OMIM# 615574) is a very rare newly described neurometabolic disorder characterized by congenital microcephaly and severe global developmental delay, associated with intractable seizures or hyperekplexia. Brain MRI typically shows cerebral atrophy with simplified gyral pattern and delayed myelination. Only 12 cases have been described to date. The disease is caused by homozygous or compound heterozygous mutations in the <italic>ASNS</italic> gene on chromosome 7q21.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Family 1 is a multiplex consanguineous family with five affected members, while Family 2 is simplex. One affected from each family was available for detailed phenotyping. Both patients (Patients 1 and 2) presented at birth with microcephaly and severe hyperekplexia, and were found to have gross brain malformation characterized by simplified gyral pattern, and hypoplastic cerebellum and pons. EEG showed no epileptiform discharge in Patient 2 but multifocal discharges in patient 1. Patient 2 is currently four years old with severe neurodevelopmental delay, quadriplegia and cortical blindness. Whole exome sequencing (WES) revealed a novel homozygous mutation in <italic>ASNS</italic> (NM_001178076.1) in each patient (c.970C&#x2009;&gt;&#x2009;T:p.(Arg324*) and c.944A&#x2009;&gt;&#x2009;G:p.(Tyr315Cys)).</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Our results expand the mutational spectrum of the recently described asparagine synthetase deficiency and show a remarkable clinical homogeneity among affected individuals, which should facilitate its recognition and molecular confirmation for pertinent and timely genetic counseling.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12883-016-0633-0) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Hyperekplexia</kwd>
        <kwd>Brain malformation</kwd>
        <kwd>Asparagine synthetase deficiency</kwd>
        <kwd><italic>ASNS</italic> gene</kwd>
        <kwd>Whole exome sequencing</kwd>
        <kwd>Arthrogryposis</kwd>
        <kwd>Case report</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>deanship of scientific researh king saud university</institution>
          </funding-source>
          <award-id>researcg group #301</award-id>
          <principal-award-recipient>
            <name>
              <surname>Salih</surname>
              <given-names>Mustafa A.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Asparagine synthetase deficiency (ASNSD, OMIM# 615574) is a very rare newly described autosomal recessive neurometabolic disorder, caused by homozygous or compound heterozygous mutations in the <italic>ASNS</italic> gene on chromosome 7q21 [<xref ref-type="bibr" rid="CR1">1</xref>]. The phenotype is characterized by microcephaly, severely delayed psychomotor development, progressive encephalopathy, cortical atrophy with reduced cerebral volume and enlarged lateral ventricles (associated in some with cerebellar and pontine hypoplasia, simplified gyral pattern, cortical dysgenesis and delayed myelination), intractable seizures or hyperekplexic activity, appendicular hypertonia and hyperreflexia [<xref ref-type="bibr" rid="CR1">1</xref>]. Other associated features include micrognathia, receding forehead, relatively large ears, axial hypotonia and cortical blindness.</p>
      <p>To the best of our knowledge, only 12 patients were described in the literature including the nine original patients reported by Ruzzo et al. [<xref ref-type="bibr" rid="CR1">1</xref>] from four families of Iranian Jewish, French Canadian, and Bangladeshi origins, two of whom were consanguineous. Two patients were subsequently reported by Alfadhel et al. [<xref ref-type="bibr" rid="CR2">2</xref>] from Saudi Arabia, and another reported by Ben-Salem et al. [<xref ref-type="bibr" rid="CR3">3</xref>] from United Arab Emirates, all born to consanguineous parents (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical features of cases with asparagine synthetase deficiency due to <italic>ASNS gene</italic> mutation</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Present report</th><th rowspan="2">Ruzzo et al. [<xref ref-type="bibr" rid="CR1">1</xref>]</th><th rowspan="2">Ben Salem et al. [<xref ref-type="bibr" rid="CR3">3</xref>]</th><th rowspan="2">Alfadhel et al. [<xref ref-type="bibr" rid="CR2">2</xref>]</th></tr><tr><th/><th>Patient 1</th><th>Patient 2</th></tr></thead><tbody><tr><td>Number of pts</td><td>2</td><td/><td>9</td><td>1</td><td>2</td></tr><tr><td>Number of families</td><td>2</td><td/><td>4</td><td>1</td><td>1</td></tr><tr><td>Age</td><td>1 month</td><td>4 Yrs</td><td>9 month&#x2013;14 Yrs</td><td>5 Yrs</td><td>2 Yrs/4 Yrs</td></tr><tr><td>Gender</td><td>M</td><td>M</td><td>8M/1F</td><td>M</td><td>1M/1F</td></tr><tr><td rowspan="2">Ethnic origin</td><td rowspan="2">Arab</td><td rowspan="2">Arab</td><td>Iranian Jews, French</td><td rowspan="2">Arab</td><td rowspan="2">Arab</td></tr><tr><td>Canadian, Bangladeshi</td></tr><tr><td>Consanguinity</td><td>Yes</td><td>Yes</td><td>Yes in two families</td><td>Yes</td><td>Yes</td></tr><tr><td rowspan="3">Mutation in <italic>ASNS</italic> gene</td><td>c.1219C&#x2009;&gt;&#x2009;T</td><td>c.944A&#x2009;&gt;&#x2009;G</td><td>c. 1084T&#x2009;&gt;&#x2009;G(p.Phe 362Val</td><td rowspan="3">c. 1193 A&#x2009;&gt;&#x2009;C p.Y 398 C</td><td>c. 1160A&#x2009;&gt;&#x2009;G</td></tr><tr><td rowspan="2">p.(Arg407)</td><td rowspan="2">p.Y 315 C</td><td>c. 1648C&#x2009;&gt;&#x2009;T(p.Arg 550Cys</td><td rowspan="2">p. Tyr 377Cys</td></tr><tr><td>c 17C&#x2009;&gt;&#x2009;A(p. A6E</td></tr><tr><td>Type of mutation</td><td>Nonsense homozygous</td><td>Missense, homozygous</td><td>Missense, homozygous, compound heterozygous</td><td>Missense, homozygous</td><td>Missense, homozygous</td></tr><tr><td>Developmental delay</td><td/><td>Severe</td><td>Severe</td><td>Severe</td><td>Severe</td></tr><tr><td>Head circumference (cm )at birth</td><td>29</td><td>29</td><td>28.5&#x2013;33</td><td>29.5</td><td>30 and 26.5</td></tr><tr><td>Hypertonia</td><td>No</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td></tr><tr><td>Spastic quadriplegia</td><td>No</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td></tr><tr><td>Seizure</td><td>Yes</td><td>No</td><td>6 patients</td><td>Yes</td><td>Yes, both</td></tr><tr><td>Hyperekplexia</td><td>Yes</td><td>Yes</td><td>Three patients</td><td>No</td><td>No</td></tr><tr><td>EEG Pattern</td><td>Epileptic encephalopathy in a transitional phase with predominant SZ burdens</td><td>Low amplitude bilaterally but no clear epileptiform discharge</td><td>&#x2022; Disorganized background In hyperekplexia cases<break/>&#x2022; Hypsarrhythmia<break/>&#x2022; Suppression burst</td><td>Abnormal background activity bilaterally, low amplitude and frequent interictal multifocal spike</td><td>Multiple independent spike foci</td></tr><tr><td>MRI Brain</td><td>Microcephaly, smooth thin cerebral cortex, simplified gyral pattern, global brain atrophy, delayed myelination, hypoplastic cerebellum and pons</td><td>Microcephaly, smooth thin cerebral cortex, simplified gyral pattern, global brain atrophy, delayed myelination, hypoplastic cerebellum and pons</td><td>All have severe microcephaly, brain atrophy delayed myelination, decreased size of the pons and simplified gyral pattern</td><td>Severe microcephaly thin corpus callosum, ventriculomegaly, brain atrophy, decreased size of pons, simplified gyral pattern</td><td>Both severe microcephaly brain atrophy, delayed myelination and simplified gyral pattern</td></tr></tbody></table><table-wrap-foot><p>
<italic>Abbreviations</italic>: <italic>M</italic> male, <italic>F</italic> female, <italic>Yrs</italic> years, <italic>EEG</italic> electroencephalography, <italic>MRI</italic> magnetic resonance image</p></table-wrap-foot></table-wrap></p>
      <p>In this report, we describe two additional cases from Saudi Arabia belonging to two consanguineous families, with typical clinical and radiological features of ASNSD. The diagnosis was confirmed by whole exome sequencing (WES), which revealed two novel mutations in the <italic>ASNS</italic> gene. This is the fourth ASNSD report in the literature.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <sec id="Sec3">
        <title>Patient 1</title>
        <p>The proband (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, V: 2) is 1-month-old Saudi boy born normally at term to first 24-year- old parents. Four maternal aunts (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, IV: 1, 4, 7, 8.) had died at the age of four, five, three and six weeks respectively, in a remote medical facility with no available records. However, all are said to have presented with microcephaly and abnormal movements similar to the index (see below). The mother was G2P1 (IUFD at 28&#xA0;weeks gestation) +0. No history of exposures. Antenatal ultrasound (US) scan showed microcephaly. Apgar score was 9 and 10 at one and five minutes, respectively. Birth weight 2675gm (10<sup>th</sup> percentile), head circumference 29&#xA0;cm (&#x2212;3SD). Examination showed microcephaly, sloping forehead, short neck, and micrognathia (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>). Shortly after birth, he developed abnormal movements in the form of bursts of tonic/clonic movements provoked by non-habituating glabellar and root of the nose tapping, sound and light (see Additional files <xref rid="MOESM1" ref-type="media">1</xref>, <xref rid="MOESM2" ref-type="media">2</xref> and <xref rid="MOESM3" ref-type="media">3</xref>). There was hyperreflexia, hypertonia and arthrogryposis of the lower limbs. He developed frequent apneas necessitating mechanical ventilation. Treatment with clonazepam was initiated and later phenobarbitone was added to control the abnormal movements. Laboratory investigations (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>) showed normal metabolic screen including plasma and CSF asparagine, glutamine, aspartate and glutamate.CSF neurotransmitters, 5HIAA, 3-OMD, and HVA were normal. Brain MRI (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>) revealed cerebral atrophy, simplified gyral pattern and hypoplastic cerebellum and pons. EEG showed multifocal discharges, fast spiking in the left hemisphere favoring cortical dysplasia, and frontal spikes. The findings favor epileptic encephalopathy in a transitional phase with predominant seizure burdens. Whole exome sequence (WES) revealed nonsense mutation in the <italic>ASNS</italic> gene, (NM_001178076.1: c.970C&#x2009;&gt;&#x2009;T p. (Arg324*). He died at the age of six weeks in status epilepticus.<fig id="Fig1"><label>Fig. 1</label><caption><p>Pedigrees of the two study families. The sequence chromatograms of the mutant alleles are shown below the respective pedigrees</p></caption><graphic xlink:href="12883_2016_633_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>
<bold>a</bold> Photograph of patient 1 showing microcephaly, slopingforehead, micrognathia, and relatively large ears. <bold>b</bold> Photograph of patient 2 at age of four years. Note microcephaly, relatively large ears, sloping forehead, and severe contractures of all limbs (spastic quadriplegic posture)</p></caption><graphic xlink:href="12883_2016_633_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Biochemical findings in patient 1</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Test</th><th>Plasma</th><th>Reference range</th><th>Cerebrospinal fluid</th><th>Reference range</th></tr></thead><tbody><tr><td>Asparagine (&#x3BC; <italic>mol</italic>/L)</td><td>55</td><td>25&#x2013;91</td><td>5</td><td>0&#x2013;12</td></tr><tr><td>Glutamine (&#x3BC; <italic>mol</italic>/L)</td><td>834</td><td>316&#x2013;1020</td><td>639</td><td>232&#x2013;725</td></tr><tr><td>Glutamic acid (&#x3BC; <italic>mol</italic>/L)</td><td>125</td><td>31&#x2013;202</td><td>2</td><td>0&#x2013;27</td></tr><tr><td>Aspartic acid (&#x3BC; <italic>mol</italic>/L)</td><td>33</td><td>2&#x2013;20</td><td>&lt;1</td><td>0&#x2013;3</td></tr><tr><td colspan="5">CSF Neurotransmitters</td></tr><tr><td colspan="3">&#x2003;5-hydoxyindoleacetic acid(5HIAA) (n mol/L)</td><td>281</td><td>Newborn (208&#x2013;1159)</td></tr><tr><td colspan="3">&#x2003;Homovanillic acid (HVA) (n mol/L)</td><td>410</td><td>Newborn (337&#x2013;1299)</td></tr><tr><td colspan="3">&#x2003;3-O-methyldopa (3-OMD) (n mol/L)</td><td>79</td><td>Newborn (0&#x2013;300)</td></tr><tr><td>&#x2003;Urine organic acid</td><td colspan="4">Normal</td></tr></tbody></table></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>Brain MR images at day 1 after birth of patient 1. <bold>a</bold> Sagittal T1-weighted image showing severe microcephaly, simplified gyral pattern, thin corpus callosum, small cerebellum, and small pons. <bold>b</bold> Axial T1-weighted image demonstrating small pons and cerebellum. <bold>c</bold> Axial T1-weighted image showing delayed myelination of the posterior limb of internal capsule, bilaterally. <bold>d</bold> Coronal FLAIR image demonstrating severely simplified gyral pattern and large extra-axial CSF spaces reflecting brain underdevelopment. <bold>e</bold> Proton MR Spectroscopy with long TE showing normal spectra for age</p></caption><graphic xlink:href="12883_2016_633_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Patient 2</title>
        <p>Is a 4- year-old Saudi boy delivered normally at term to a 23-year-old primigravida lady and her 25-year-old first cousin husband (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, IV:1). Antenatal US scan revealed microcephaly but pregnancy was uneventful otherwise. Apgar score was 9 and 10 at one and five minutes, respectively. Birth weight 2790 gm (25<sup>th</sup> percentile), length 51&#xA0;cm (50<sup>th</sup> percentile) and head circumference 30&#xA0;cm (&#x2212;2.6SD). He was admitted to the Neonatal Intensive Care Unit (NICU) because of microcephaly and abnormal movements. Clinical examination showed microcephaly, staring anxious look, sloping forehead, receding chin and relatively large ears. Neurological examination revealed tonic/clonic rapid movements of both upper and lower limbs, with positive head retraction reflex (HRR). The attacks were provoked by glabellar and tip of the nose tapping, were non-habituating and precipitated by sounds. Additional files <xref rid="MOESM4" ref-type="media">4</xref>, <xref rid="MOESM5" ref-type="media">5</xref>, and <xref rid="MOESM6" ref-type="media">6</xref> show this in more detail. Hypertonia with exaggerated reflexes and arthrogryposis of both upper and lower limbs were also noted. The rest of the systemic examination revealed no abnormality. He was initially managed by phenobarbitone. Clonazepam and levetiracetam were later added due to the intractable movements. At the age of four years he was found to have profound global developmental delay and spastic quadriplegia with severe contractures of both upper and lower limbs (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). He also had cortical blindness and hyperekplexic activities could still be elicited by glabellar and root of the nose tapping, light and sounds [see Additional files <xref rid="MOESM1" ref-type="media">1</xref>, <xref rid="MOESM2" ref-type="media">2</xref>, <xref rid="MOESM3" ref-type="media">3</xref>, <xref rid="MOESM4" ref-type="media">4</xref>, <xref rid="MOESM5" ref-type="media">5</xref> and <xref rid="MOESM6" ref-type="media">6</xref>]. His growth parameters were severely retarded: his weight 5.3 Kg (&#x2212;6.8SD) and head circumference was 35&#xA0;cm (&#x2212;10.1SD).</p>
        <p>Laboratory tests including hematologic indices, renal function, liver function, and electrolytes were all normal. Metabolic screen, plasma amino acids, lactate, and ammonia were unremarkable. Chromosome study revealed normal male karyotype. MRI brain (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) showed microcephaly, thin and smooth cortex with simplified gyral pattern [<xref ref-type="bibr" rid="CR4">4</xref>], delayed myelination, dilatation of the ventricles, global brain atrophy and hypoplastic cerebellum and pons. EEG showed very low amplitude bilaterally without epileptiform discharges. Only sporadic sharp transient spikes, most likely myogenic in origin, were noted. Genetic testing, utilizing whole exome sequencing (WES), showed a novel homozygous <italic>ASNS</italic> gene mutation: NM_001178076.1, missense c.944A&#x2009;&gt;&#x2009;G, <italic>p. (</italic>Tyr315Cys<italic>)</italic>. Both parents are heterozygous carriers. This change was absent in 615 in-house Saudi exomes, and is predicted pathogenic by PolyPhen (0.992), SIFT (1.0) and CADD (28.7) [<xref ref-type="bibr" rid="CR5">5</xref>]. The family was offered genetic counselling.<fig id="Fig4"><label>Fig. 4</label><caption><p>MRI brain at the age of 3&#xA0;weeks. <bold>a</bold> Sagittal T1-weighted image showing severe microcephaly with overlapped lambdoid sutures, brain underdevelopment evident by simplified gyral pattern, small cerebellum, and small pons. <bold>b</bold> Axial FLAIR image revealing small pons and cerebellum. <bold>c</bold> Axial T1-weighted image demonstrating delayed myelination evident by absent myelination of the posterior limb of internal capsule, bilaterally. <bold>d</bold> Coronal T2-weighted image showing simplified gyral pattern (more in the frontal lobes) and large extra-axial CSF spaces due to brain underdevelopment</p></caption><graphic xlink:href="12883_2016_633_Fig4_HTML" id="MO4"/></fig></p>
        <p>We report two novel mutations in the <italic>ASNS</italic> gene in two Saudi patients from first cousin marriages who presented with congenital microcephaly, hyperekplexia, cerebral atrophy, simplified gyral pattern, and hypoplastic cerebellum and pons (Figs.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>). The phenotype is consistent with the recently described ASNSD (OMIM# 615574). <italic>ASNS</italic> encodes an asparagine synthetase enzyme involved in the synthesis of asparagine from glutamine and aspartate [<xref ref-type="bibr" rid="CR6">6</xref>]. The neurological impairment resulting from <italic>ASNS</italic> mutation can be explained by asparagine depletion in the brain or by accumulation of aspartate /glutamate leading to enhanced excitation and neuronal damage [<xref ref-type="bibr" rid="CR1">1</xref>]. To date five pathogenic mutations in the <italic>ASNS</italic> gene have been identified (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).</p>
        <p>All cases of asparagine synthetase deficiency were diagnosed by molecular genetics as there is no reliable biochemical test for diagnosing the disorder. Alfadhel et al. [<xref ref-type="bibr" rid="CR2">2</xref>] reported low levels of asparagine in the CSF of two siblings with ASNSD confirmed by molecular genetics, while Ruzzo et al. [<xref ref-type="bibr" rid="CR1">1</xref>] reported low asparagine levels in the CSF of only two of the five patients with the disorder. Our two patients had normal plasma and CSF asparagine, glutamine, aspartate, and glutamate and CSF neurotransmitters (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). Therefore, this condition cannot be ruled out by normal plasma and CSF asparagine, aspartate and glutamate levels (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>) in a patient presenting with congenital microcephaly, and unexplained encephalopathy in the form of intractable seizures or hyperekplexia [<xref ref-type="bibr" rid="CR1">1</xref>].<table-wrap id="Tab3"><label>Table 3</label><caption><p>Biochemical Findings in ASNSD</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="4">Plasma</th><th colspan="4">Cerebrospinal fluid (CSF)</th><th/></tr><tr><th/><th>Asparagine &#x3BC;mol/L</th><th>Glutamine &#x3BC;mol /L</th><th>Aspartate &#x3BC;mol /L</th><th>Glutamate &#x3BC;mol /L</th><th>Asparagine &#x3BC;mol /L</th><th>Glutamine &#x3BC;mol /L</th><th>Aspartate &#x3BC;mol /L</th><th>Glutamate &#x3BC;mol /L</th><th>Comment</th></tr></thead><tbody><tr><td colspan="10">A. Present Report (2015)</td></tr><tr><td>&#x2003;Patient 1</td><td>55 (25&#x2013;91)</td><td>834 (316&#x2013;1020)</td><td>33 (2&#x2013;20)</td><td>125 (31&#x2013;202)</td><td>5 (0&#x2013;12)</td><td>639 (232&#x2013;725)</td><td>&lt;1 (0&#x2013;3)</td><td>2 (0&#x2013;27)</td><td>Slightly Elevated Plasma Aspartate</td></tr><tr><td>&#x2003;Patient 2</td><td>Normal</td><td>Normal</td><td>Normal</td><td>Normal</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td/></tr><tr><td colspan="10">B. Majid Alfadhel et. al (2014) [<xref ref-type="bibr" rid="CR2">2</xref>]</td></tr><tr><td>&#x2003;Patient 1</td><td>10 (33&#x2013;68.4)</td><td>339 (254&#x2013;823)</td><td>N/A</td><td>N/A</td><td>Not detected (1.1&#x2013;6.9)</td><td>922 (356&#x2013;680)</td><td>N/A</td><td>N/A</td><td>Low Plasma and CSF Asparagine</td></tr><tr><td>&#x2003;Patient 2</td><td>6 (33&#x2013;68.4)</td><td>328 (254&#x2013;823)</td><td>N/A</td><td>N/A</td><td>1 (1.1&#x2013;6.9)</td><td>574 (356&#x2013;680)</td><td>N/A</td><td>N/A</td><td>Low Plasma and CSF Asparagine</td></tr><tr><td colspan="10">C. Ruzzo el. al (2013) [<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td>&#x2003;1</td><td>57 (23&#x2013;112)</td><td>1250 (254&#x2013;823)</td><td>18 (1&#x2013;24)</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>High Plasma Glutamate</td></tr><tr><td>&#x2003;2</td><td>49 (23&#x2013;112)</td><td>1149 (254&#x2013;823)</td><td>2 (1&#x2013;24)</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>High Plasma Glutamate</td></tr><tr><td>&#x2003;3</td><td>N/A</td><td>N/A</td><td>7 (17&#x2013;21)</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>Low Plasma Aspartate</td></tr><tr><td>&#x2003;4</td><td>12 (16&#x2013;21)</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>Low Plasma Asparagine</td></tr><tr><td>&#x2003;5</td><td>N/A</td><td>N/A</td><td>12 (0&#x2013;20)</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td/></tr><tr><td>&#x2003;6</td><td>11 (31&#x2013;56)</td><td>439 (474&#x2013;736)</td><td>7 (4&#x2013;18)</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>Low Plasma Asparagine</td></tr><tr><td>&#x2003;7</td><td>55 (31&#x2013;56)</td><td>668 (474&#x2013;736)</td><td>9 (4&#x2013;18)</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td/></tr><tr><td>Ben-Salem et. al (2015)</td><td>Normal</td><td>Normal</td><td>Normal</td><td>Normal</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td/></tr></tbody></table><table-wrap-foot><p>Legend: N/A Not Available</p></table-wrap-foot></table-wrap></p>
        <p>ASNSD is a very rare disorder with a prevalence of &lt;1/1000000 worldwide (ORPHA 391376); and hitherto, only 12 cases have been reported. We suspect this condition is underdiagnosed due to lack of recognition and the risk of confusing the hyperekplexia phenotype for nonspecific neonatal epilepsy, and also due to lack of a specific laboratory test and the difficulty of performing molecular genetic testing in suspected cases except in research centers or referral hospitals. Given that there is no reliable biochemical test, sequencing of ASNS is the mainstay of diagnosis. While our two patients were diagnosed using WES, this gene can easily be targeted by Sanger sequencing or added to a gene panel approach as described before [<xref ref-type="bibr" rid="CR7">7</xref>]. The clinical and radiographic presentation of our patients, namely congenital microcephaly, hyperekplexia, brain malformation, and (in long term survivors) severe psychomotor retardation and cortical blindness is identical to that observed in the patients reported by Ruzzo et al. [<xref ref-type="bibr" rid="CR1">1</xref>] with <italic>ASNS</italic> gene mutation. Interestingly, we previously [<xref ref-type="bibr" rid="CR8">8</xref>] reported six patients with a similar presentation of hyperekplexia, microcephaly and brain malformations who later proved to have cathepsin deficiency (CTSD) known to be associated with congenital ceroid lipofuscinosis neuronal 10 (CLN 10) [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Our observation raises the intriguing possibility of a link between asparagine synthetase deficiency and cathepsin deficiency, although this will require future research. Both disorders should be considered in microcephalic neonates who present with seizures or hyperekplexia at or before birth, and molecular genetic testing needs to be performed for pertinent and timely genetic counseling. This will pave the way for adopting effective preventive and therapeutic approaches like preimplantation genetic diagnosis (PGD), or early termination of affected pregnancies, which helped many families in this region with high prevalence of autosomal recessive disorders [<xref ref-type="bibr" rid="CR11">11</xref>]. Therapeutic approach by supplementation with asparagine in ASNSD seems attractive. However, the prenatal onset of the microcephaly and early postnatal presentation make such treatment unlikely to be curative unless started prenatally [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec5" sec-type="conclusion">
      <title>Conclusion</title>
      <p>we expand the allelic heterogeneity of ASNSD and emphasize the clinical homogeneity of this disorder. The remarkable clinical overlap with CTSD-related CLN10 makes it difficult to segregate the two disorders clinically and highlights the need for ANSN and CTSD sequencing to make an accurate diagnosis.</p>
    </sec>
    <sec id="Sec6">
      <title>Abbreviations</title>
      <p>3-OMD, 3-O-Methyldopa; 5HIAA, 5 hydroxy indole acetic acid; ASNS, asparagine synthetase; ASNSD, asparagine synthetase deficiency; CLN, ceroid lipofuscinosis neuronal; CSF, cerebrospinal fluid; CTSD, cathepsin D; EEG, electroencephalogram; HRR, head retraction reflex; HVA, homo vanillic acid; IUFD, intra uterine fetal death; MRI, magnetic resonance image; NICU, neonatal intensive care unit; PGD, preimplantation genetic diagnosis; SD, standard deviation; US, ultrasound; WES, whole exome sequence</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec7">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="12883_2016_633_MOESM1_ESM.mp4" id="MOESM1">
              <label>Additional file 1:</label>
              <caption>
                <p>MOV showing non-habituating glabellar and root of the nose tapping in patient 1 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>,V.2). (MP4 9415 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_633_MOESM2_ESM.mp4" id="MOESM2">
              <label>Additional file 2:</label>
              <caption>
                <p>MOV shows exaggerated startle reflex to sounds in patient 1 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>,V.2). (MP4 8851 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_633_MOESM3_ESM.mp4" id="MOESM3">
              <label>Additional file 3:</label>
              <caption>
                <p>MOV shows exaggerated startle reflex to light in patient 1 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>,V.2). (MP4 3117 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_633_MOESM4_ESM.mp4" id="MOESM4">
              <label>Additional file 4:</label>
              <caption>
                <p>MOV showing non-habituating glabellar and root of the nose tapping in patient 2 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>IV .1), in the first week of life. (MP4 3050 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_633_MOESM5_ESM.mp4" id="MOESM5">
              <label>Additional file 5:</label>
              <caption>
                <p>MOV shows exaggerated startle reflex to sound in patient 2 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>IV .1), at the age of 4 years. (MP4 3052 kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_633_MOESM6_ESM.mp4" id="MOESM6">
              <label>Additional file 6:</label>
              <caption>
                <p>MOV shows exaggerated startle reflex to light in patient 2 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>IV .1), at the age of 4 years. (MP4 2722 kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors are grateful to the reported family for participation. We thank the Genotyping and Sequencing Core Facilities at KFSHRC for their technical help. We also thank Mais Hashem, Firdous Abdulwahab and Niema Ibrahim, clinical research coordinators, for their help in recruiting the two families. This work was supported by KCAST grant 13-BIO1113-20 (FSA) and King Salman Center for Disability Research (FSA).Thanks are also due to Thamer Aloudah and Vir Salvador for medical illustration.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>M.A.S. was supported by the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia through the research group project number RGP-VPP-301.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>Data supporting our findings in this case report can be found in the Figs.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>, and Tables&#xA0;<xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref> in the manuscript and supplementary materials (Additional files <xref rid="MOESM1" ref-type="media">1</xref>, <xref rid="MOESM2" ref-type="media">2</xref>, <xref rid="MOESM3" ref-type="media">3</xref>, <xref rid="MOESM4" ref-type="media">4</xref>, <xref rid="MOESM5" ref-type="media">5</xref> and <xref rid="MOESM6" ref-type="media">6</xref>.Videos).</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>MZS and MAS conceived of the study, and participated in its design and coordination and drafted the manuscript. OBA, AS, K Al H, AMM. And, MSB, participated in management of patients and data analysis. MA, and, RS, carried out the molecular genetic studies. IAA, studied the radiology, MMUK reported the EEG. FSA designed and coordinated the molecular genetic studies and critically reviewed the manuscript. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the guardians of both patients for publication of this study and the accompanying images and videos. A copy of the written consents is available for review by the Editor-in-Chief of BMC Neurology, (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a, b</xref>, Additional files <xref rid="MOESM1" ref-type="media">1</xref>, <xref rid="MOESM2" ref-type="media">2</xref>, <xref rid="MOESM3" ref-type="media">3</xref>, <xref rid="MOESM4" ref-type="media">4</xref>, <xref rid="MOESM5" ref-type="media">5</xref> and <xref rid="MOESM6" ref-type="media">6</xref>).</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>The families were enrolled in the study,an informed written consent was used to recruit the patients and their relatives (King Faisal Specialist Hospital and research Center [KFSH/RC]IR13 approved research protocol.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruzzo</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Capo-Chichi</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ben-Zeev</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chitayat</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pappas</surname>
              <given-names>AL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy</article-title>
          <source>Neuron</source>
          <year>2013</year>
          <volume>80</volume>
          <fpage>429</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2013.08.013</pub-id>
          <pub-id pub-id-type="pmid">24139043</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Alfadhel M, Alrifai MT, Trujillano D, Alshaalan H, AlOthaim A, Al Rasheed S, et al. Asparagine synthetase deficiency :new inborn error of metabolism. JIMD Reports. 2014: doi:10.1007/8904_2014-405.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ben&#x2013;Salem</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gleeson</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Al-Shamsi</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Islam</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hertecant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Al-Gazali</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay</article-title>
          <source>Metab Brain Dis</source>
          <year>2015</year>
          <volume>30</volume>
          <fpage>687</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1007/s11011-014-9618-0</pub-id>
          <pub-id pub-id-type="pmid">25227173</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alazami</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shamseldin</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Anazi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Al-dosari</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Alzahrani</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families</article-title>
          <source>Cell Rep</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>2</issue>
          <fpage>148</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.015</pub-id>
          <pub-id pub-id-type="pmid">25558065</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adachi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Poduri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kawaguch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Salih</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital microcephaly with a simplified gyral pattern: associated findings and their significance</article-title>
          <source>Am J Neuroradiol</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>1123</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.3174/ajnr.A2440</pub-id>
          <pub-id pub-id-type="pmid">21454410</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Cairney</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Wills</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Andrulis</surname>
              <given-names>IL</given-names>
            </name>
          </person-group>
          <article-title>Molecular structure of the human asparagine synthetase gene</article-title>
          <source>Genomics</source>
          <year>1989</year>
          <volume>4</volume>
          <fpage>259</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1016/0888-7543(89)90329-7</pub-id>
          <pub-id pub-id-type="pmid">2565875</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shamseldin</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Tulbah</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kurdi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Nemer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alsahan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Al Mardawi</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of embryonic lethal genes in humans by autozygosity mapping and exome sequencing in consanguineous families</article-title>
          <source>Genome Biol</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>116</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-015-0681-6</pub-id>
          <pub-id pub-id-type="pmid">26036949</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seidahmed</surname>
              <given-names>MZ</given-names>
            </name>
            <name>
              <surname>Salih</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Abdulbasit</surname>
              <given-names>OB</given-names>
            </name>
            <name>
              <surname>Shaheed</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Al Hussein</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miqdad</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel syndrome of lethal familial hyperekplexia associated with brain malformation</article-title>
          <source>BMC Neurol</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>125</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2377-12-125</pub-id>
          <pub-id pub-id-type="pmid">23101555</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steinfeld</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Reinhardt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schreiber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hillebrand</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kraetzner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bruck</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cathepsin D deficiency is associated with a human neurodegenerative disorder</article-title>
          <source>Am J Hum Genet</source>
          <year>2006</year>
          <volume>78</volume>
          <fpage>988</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1086/504159</pub-id>
          <pub-id pub-id-type="pmid">16685649</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siintola</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Partanen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stromme</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Haapanen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haltia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maehlen</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis</article-title>
          <source>Brain</source>
          <year>2006</year>
          <volume>129</volume>
          <fpage>1438</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awl107</pub-id>
          <pub-id pub-id-type="pmid">16670177</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Gazali</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>Mutations of a country: a mutation review of single gene disorders in the United Arab Emirates (UAE)</article-title>
          <source>Hum Mutat</source>
          <year>2010</year>
          <volume>31</volume>
          <fpage>505</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.21232</pub-id>
          <pub-id pub-id-type="pmid">20437613</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
